Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:39 pm Purchase | 2025-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | Nantahala Capital Management, LLC | 2,244,319 9.990% | 2,244,319 (New Position) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | FMR LLC | 8,499,100 14.800% | 8,499,100 (New Position) | Filing History |
| 2025-11-03 4:09 pm Purchase | 2025-10-27 | 13G | X4 Pharmaceuticals, Inc. XFOR | Perceptive Advisors LLC | 6,064,680 7.600% | 6,064,680 (New Position) | Filing History |
| 2025-10-29 6:04 pm Purchase | 2025-10-27 | 13D | X4 Pharmaceuticals, Inc. XFOR | Growth Equity Opportunities 18 VGE, LLC | 5,057,610 6.200% | 2,813,952 (+125.42%) | Filing History |
| 2025-10-21 09:00 am Purchase | 2025-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | Empery Asset Management, LP | 2,498,162 9.990% | 2,498,162 (New Position) | Filing History |
| 2025-10-03 5:25 pm Purchase | 2025-10-03 | 13G | X4 Pharmaceuticals, Inc. XFOR | Coastlands Capital LP | 2,491,638 9.990% | 11,993 (+0.48%) | Filing History |
| 2025-09-15 4:30 pm Purchase | 2025-09-09 | 13G | X4 Pharmaceuticals, Inc. XFOR | Bain Capital Life Sciences Fund, L.P. | 2,436,588 9.990% | 62 (+0.00%) | Filing History |
| 2025-08-20 5:41 pm Purchase | 2025-08-13 | 13G | X4 Pharmaceuticals, Inc. XFOR | BIOTECHNOLOGY VALUE FUND L P | 2,243,659 9.900% | 2,243,659 (New Position) | Filing History |
| 2025-08-19 4:05 pm Purchase | 2025-08-12 | 13G | X4 Pharmaceuticals, Inc. XFOR | Deep Track Capital, LP | 2,366,995 9.990% | 2,366,995 (New Position) | Filing History |
| 2025-08-18 5:00 pm Purchase | 2025-08-11 | 13G | X4 Pharmaceuticals, Inc. XFOR | Trails Edge Capital Partners, LP | 2,317,153 9.900% | 2,317,153 (New Position) | Filing History |
| 2025-08-18 4:26 pm Purchase | 2025-08-11 | 13D | X4 Pharmaceuticals, Inc. XFOR | Coastlands Capital LP | 2,479,645 9.990% | 2,479,645 (New Position) | Filing History |
| 2025-08-15 4:54 pm Purchase | 2025-08-13 | 13D | X4 Pharmaceuticals, Inc. XFOR | Growth Equity Opportunities 18 VGE, LLC | 2,243,658 9.990% | 2,243,658 (New Position) | Filing History |
| 2025-08-14 5:53 pm Sale | 2025-06-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | ORBIMED ADVISORS LLC | 134,947 1.700% | -248,201 (-64.78%) | Filing History |
| 2025-08-13 9:40 pm Purchase | 2025-08-11 | 13D | X4 Pharmaceuticals, Inc. XFOR | Bain Capital Life Sciences Fund, L.P. | 2,436,526 9.990% | 2,436,526 (New Position) | Filing History |
| 2025-07-18 11:48 am Purchase | 2025-06-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | BlackRock Inc. BLK | 179,125 3.000% | 179,125 (New Position) | Filing History |
| 2025-01-31 10:09 am Sale | 2024-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | The Vanguard Group | 273,363 4.800% | -7,994 (-2.84%) | Filing History |
| 2024-11-12 5:59 pm Unchanged | 2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | The Vanguard Group | 281,358 5.000% | 0 (Unchanged) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | BlackRock Inc. BLK | 373,689 6.700% | 0 (Unchanged) | Filing History |
| 2024-11-04 2:15 pm Purchase | 2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | The Vanguard Group | 281,358 5.000% | 281,358 (New Position) | Filing History |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR | BlackRock Inc. BLK | 373,689 6.700% | 101,664 (+37.37%) | Filing History |